Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel enabling strategies for oral peptide delivery.

International journal of pharmaceutics·2025
Same author

Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts.

Pharmacological research·2021
Same author

Zero-order and prolonged release of atenolol from microporous FAU and BEA zeolites, and mesoporous MCM-41: Experimental and theoretical investigations.

Journal of controlled release : official journal of the Controlled Release Society·2020
Same author

Carboxymethyl guar gum nanoparticles for drug delivery applications: Preparation and preliminary in-vitro investigations.

Materials science & engineering. C, Materials for biological applications·2016
Same author

Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

Journal of controlled release : official journal of the Controlled Release Society·2014
Same author

Synthesis and characterization of N-(2-aminoethyl)-2-acetamidyl gellan gum with potential biomedical applications.

Carbohydrate polymers·2013

Related Experiment Video

Updated: Mar 14, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Carbohydrate Nanoparticles for Brain Delivery.

A Lalatsa1, E Barbu1

  • 1School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.

International Review of Neurobiology
|September 29, 2016
PubMed
Summary

Emerging carbohydrate nanoparticles offer a promising noninvasive strategy for delivering drugs across the blood-brain barrier to treat neurological diseases. Chitosan nanoparticles show significant potential, enhancing drug delivery and therapeutic effects in preclinical studies.

Keywords:
Blood–brain barrierCarbohydratesCellulose nanocrystalsChitosanCyclodextrinsDextranHyaluronic acidNanoparticlesNasalPullulan

More Related Videos

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K
Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
06:41

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

11.7K

Related Experiment Videos

Last Updated: Mar 14, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K
Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery
06:41

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

11.7K

Area of Science:

  • Nanotechnology
  • Neuroscience
  • Biomaterials Science

Background:

  • Brain tumors and neurological diseases require effective drug delivery across the blood-brain barrier (BBB).
  • Nanomedicines offer targeted delivery of potent pharmaceuticals, but crossing the BBB remains a challenge.
  • Carbohydrates are attractive for drug carriers due to biocompatibility, biodegradability, and ease of modification.

Purpose of the Study:

  • To review the latest research on carbohydrate-based nanoparticles for central nervous system (CNS) drug delivery.
  • To discuss challenges and current strategies for overcoming the BBB.
  • To highlight the potential of specific carbohydrate nanocarriers, particularly chitosan.

Main Methods:

  • Review of current literature on nanomedicine and BBB penetration strategies.
  • Focus on carbohydrate-based nanoparticles, including chitosan, dextran, pullulan, and cellulose.
  • Analysis of preclinical studies demonstrating efficacy of nanocarrier systems.

Main Results:

  • Chitosan-based nanoparticles have shown significant promise in preclinical studies.
  • These nanomedicines enhanced brain drug levels and pharmacodynamic responses via intravenous, nasal, and oral administration.
  • Other polysaccharides like dextran, pullulan, and cellulose also warrant further investigation.

Conclusions:

  • Carbohydrate nanoparticles, especially chitosan, represent a viable strategy for noninvasive CNS drug delivery.
  • Further research into various polysaccharide-based nanocarriers is crucial for advancing BBB penetration technologies.
  • Targeted nanomedicines hold great potential for treating brain disorders.